ACCESSION: MSBNK-SMB_Measured-HSA015P0132006
RECORD_TITLE: Characterized; Creatine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'EL21_pos_1191': {'bp': 1664485.0, 'sum': 3877008.0}, 'EL19_pos_1197': {'bp': 1386994.0, 'sum': 3290516.0}, 'EL03_pos_1239': {'bp': 1363525.0, 'sum': 3897627.0}, 'EL13_pos_1191': {'bp': 1361191.0, 'sum': 3977591.0}, 'EL15_pos_1191': {'bp': 1028692.0, 'sum': 2902158.0}, 'EL05_pos_1191': {'bp': 856587.0, 'sum': 2360397.0}, 'EL06_pos_1191': {'bp': 711903.0, 'sum': 1955524.0}, 'EL23_pos_1191': {'bp': 653255.0, 'sum': 1923207.0}, 'EL16_pos_1187': {'bp': 545289.0, 'sum': 1713535.0}, 'EL24_pos_1197': {'bp': 432761.0, 'sum': 1380671.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 132.076955
COMMENT: PRECURSOR_M/Z_STDEV 0.000047
COMMENT: PRECURSOR_IN_MS1 mz 132.076741; int 66.241; delta(ppm) 0.732696
COMMENT: PROPOSED_CHARGE_STATE +1; mz 133.080031; int 3.046; cor 0.976
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.092; C4H9N3O2; [M+H]+; delta(ppm) -0.091555
COMMENT: PROPOSED_MF MS-FINDER 3.636; C4H9N3O2; [M+H]+; delta(ppm) -0.090744
COMMENT: PROPOSED_MF SIRIUS5_Sirius 30.254; C4H9N3O2; [M+H]+; delta(ppm) -0.090744
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H9N3O2; [M+H]+; delta(ppm) -0.090744
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.862; C4H9N3O2; [M+H]+; delta(ppm) -0.090744
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.242; C2H7N6O; [M+H]+; delta(ppm) 10.075141
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.964; C6H11O3; [M+H]+; delta(ppm) -10.256423
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9N3O2; [M+H]+; delta(ppm) -0.090744
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.814; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; O=C(O)C(NC(=N)N)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.562; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; NC(=N)NCCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.554; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; C(C(C(=O)N)N)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.506; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; CN(CC(O)=O)C(N)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.506; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; O=C(N)C(=O)NCCN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.471; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; Creatine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.748; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; Beta-Guanidinopropionic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.645; WXOFJMWQRNARBH-UHFFFAOYSA-N; [M+H]+; 2-[diaminomethylene(methyl)ammonio]acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.592; HQAXXRWVFPWZIL-ALCCZGGFSA-N; [M+H]+; UNPD163851
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.572; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; N-Amidinoalanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.447; HQETVJNRDIVRPA-UHFFFAOYSA-N; [M+H]+; 3-(N'-aminomethanimidamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.355; BYUOAQWHIKQRNX-UHFFFAOYSA-N; [M+H]+; methyl 2-(diaminomethylideneamino)acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.313; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; CNP0447118
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.274; KUGBOAOPCUFIJN-UHFFFAOYSA-N; [M+H]+; (diaminomethylideneamino) propanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.222; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; (2S)-2-aminobutanediamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.222; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KUGBOAOPCUFIJN-UHFFFAOYSA-N; [M+H]+; (diaminomethylideneamino) propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.713; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.677; VTYMULRIBAMCLK-UHFFFAOYSA-N; [M+H]+; CNP0447118
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.676; HQAXXRWVFPWZIL-ALCCZGGFSA-N; [M+H]+; UNPD163851
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.652; BYUOAQWHIKQRNX-UHFFFAOYSA-N; [M+H]+; methyl 2-(diaminomethylideneamino)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.624; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; Creatine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.624; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; Beta-Guanidinopropionic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.624; WXOFJMWQRNARBH-UHFFFAOYSA-N; [M+H]+; 2-[diaminomethylene(methyl)ammonio]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.624; DVNFLGLGNLXITH-UHFFFAOYSA-N; [M+H]+; N-Amidinoalanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.180; DSLBDPPHINVUID-REOHCLBHSA-N; [M+H]+; (2S)-2-aminobutanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.092; HQETVJNRDIVRPA-UHFFFAOYSA-N; [M+H]+; 3-(N'-aminomethanimidamido)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.876; CVSVTCORWBXHQV-UHFFFAOYSA-N; [M+H]+; 2-[carbamimidoyl(methyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.481; KMXXSJLYVJEBHI-UHFFFAOYSA-N; [M+H]+; 3-(diaminomethylideneamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.335; YGGSSUISOYLCBF-UHFFFAOYSA-N; [M+H]+; 1-nitroso-1-propylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; LOEHVDVYTQIWEV-UHFFFAOYSA-N; [M+H]+; 1,1,3-trimethyl-3-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; DVNFLGLGNLXITH-REOHCLBHSA-N; [M+H]+; (2S)-2-(diaminomethylideneamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; MQLQMSXXDOSWKY-UHFFFAOYSA-N; [M+H]+; 1-ethyl-3-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; IHSMGJQJILYALZ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; VQBVPDAUEBSGMB-UHFFFAOYSA-N; [M+H]+; 1-N,1-N'-dimethyl-2-nitroethene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; YALSARYKNGABLL-UHFFFAOYSA-N; [M+H]+; ethyl 2-(aminohydrazinylidene)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.365; HGMBEFYZNDKFQJ-UHFFFAOYSA-N; [M+H]+; 2-[(2-amino-2-oxoethyl)amino]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.332; CGJFKQFYZOARRV-UHFFFAOYSA-N; [M+H]+; 2-(2-azidoethoxy)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -11.605; CVSVTCORWBXHQV; [M+H]+; creatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.839; DVNFLGLGNLXITH; [M+H]+; NCIStruc1_001820
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -82.292; KMXXSJLYVJEBHI; [M+H]+; beta-GPA
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.657; WXOFJMWQRNARBH; [M+H]+; methylguanidinoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.041; HGMBEFYZNDKFQJ; [M+H]+; Acetamide, 2,2''-iminobis-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.001; IHSMGJQJILYALZ; [M+H]+; 1-Nitroso-1-methyl-3-ethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.687; HQAXXRWVFPWZIL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.313; LOEHVDVYTQIWEV; [M+H]+; Nitrosotrimethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.323; VTYMULRIBAMCLK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.035; YGGSSUISOYLCBF; [M+H]+; Nitrosopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.129; VQBVPDAUEBSGMB; [M+H]+; 1,1-Ethenediamine, N,N''-dimethyl-2-nitro-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.380; DSLBDPPHINVUID; [M+H]+; Aspartamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.013; MQLQMSXXDOSWKY; [M+H]+; 1-ethyl-3-methyl-1-nitrosourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.754; CVSVTCORWBXHQV; [M+H]+; creatine
COMMENT: CONFIDENCE Level 3: Tentative candidate, Creatine, CVSVTCORWBXHQV-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (4), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (6), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000064;
CH$NAME: Creatine
CH$NAME: 2-[carbamimidoyl(methyl)amino]acetic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H9N3O2
CH$EXACT_MASS: 131.069477
CH$SMILES: CN(CC(=O)O)C(=N)N
CH$IUPAC: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)
CH$LINK: CHEBI CHEBI:16919
CH$LINK: HMDB HMDB0000064
CH$LINK: INCHIKEY CVSVTCORWBXHQV-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:586
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.919
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 132.076741
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000f-9200000000-3c0a12122ceb57193db5
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.9952314 67.5149 58.995955 0.7458 18.48 0.7818 10 ?
  61.0108821 23.3741 61.011612 0.7540 6.69 0.7455 10 ?
  84.0638157 18.3458 84.064531 0.9279 5.31 0.7381 8 ?
  86.9899747 31.6057 86.990677 0.7012 9.42 0.7576 10 ?
  87.0553450 46.6580 87.056047 1.0683 6.07 0.9758 10 f{C3H7N2O1}/0.64ppm,p-C1H3N1O1
  88.0215779 841.8293 88.022275 0.2499 194.80 0.7697 10 ?
  90.0549783 999.0000 90.055664 0.2221 38.51 1.0000 10 f{C3H8N1O2}/0.26ppm,p-C1H2N2
  90.9032161 31.2354 90.903897 0.9791 15.30 0.0333 9 ?
  105.0698750 19.5142 105.070439 1.6085 8.96 0.4286 8 ?
  114.0661799 22.1454 114.066671 0.9907 5.03 0.9667 9 f{C4H8N3O1}/-0.07ppm,p-H2O1
  130.9819034 27.5284 130.982227 1.2674 14.22 -0.2167 9 ?
  132.0767867 385.9777 132.077097 0.2650 31.16 1.0000 10 f{C4H10N3O2}/0.26ppm,p
  134.0270905 82.7616 134.027377 0.6267 18.47 0.6970 10 ?
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  58.995231 67.51 67
  61.010882 23.37 23
  84.063816 18.35 18
  86.989975 31.61 31
  87.055345 46.66 46
  88.021578 841.83 841
  90.054978 999.00 999
  90.903216 31.24 31
  105.069875 19.51 19
  114.066180 22.15 22
  130.981903 27.53 27
  132.076787 385.98 385
  134.027091 82.76 82
//
